WBB Securities Downgrades Turn Therapeutics to Sell, Announces $10 Price Target
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsDowngradesPrice Target
WBB Securities analyst Karen Sterling downgrades Turn Therapeutics (NASDAQ:TTRX) from Hold to Sell and announces $10 price target.
WBB Securities analyst Karen Sterling downgrades Turn Therapeutics (NASDAQ:TTRX) from Hold to Sell and announces $10 price target.